Insider Buy/Sell Ratio — Last 7 Days
Ratio0.2:1
Daily Buy & Sell Volume
By Sector
Technology
Buys14
Sells515
Buy $$3.16M
Sell $$596.03M
Ratio1:188.65
% Change vs. Prior
Ratio -99.4%Value -72.2%
Energy
Buys6
Sells64
Buy $$182.41K
Sell $$271.71M
Ratio1:1489.56
% Change vs. Prior
Ratio -90.4%Value -89.8%
Industrials
Buys33
Sells97
Buy $$6.24M
Sell $$154.52M
Ratio1:24.75
% Change vs. Prior
Ratio -36.3%Value -58.7%
Healthcare
Buys24
Sells219
Buy $$25.00M
Sell $$110.47M
Ratio1:4.42
% Change vs. Prior
Ratio +1028.0%Value -98.3%
Financial Services
Buys115
Sells72
Buy $$4.70M
Sell $$72.76M
Ratio1:15.49
% Change vs. Prior
Ratio -59.6%Value -53.7%
Consumer Cyclical
Buys22
Sells75
Buy $$1.62M
Sell $$59.24M
Ratio1:36.61
% Change vs. Prior
Ratio -99.0%Value -80.8%
Consumer Defensive
Buys14
Sells57
Buy $$3.66M
Sell $$25.61M
Ratio1:7.00
% Change vs. Prior
Ratio +411.0%Value -92.8%
Basic Materials
Buys14
Sells13
Buy $$2.29M
Sell $$15.47M
Ratio1:6.75
% Change vs. Prior
Ratio -70.1%Value -84.1%
Real Estate
Buys5
Sells12
Buy $$688.85K
Sell $$9.67M
Ratio1:14.04
% Change vs. Prior
Ratio -52.2%Value -65.8%
Communication Services
Buys2
Sells29
Buy $$10.67K
Sell $$9.57M
Ratio1:896.30
% Change vs. Prior
Ratio -99.0%Value -94.9%
Utilities
Buys0
Sells12
Buy $$0.00
Sell $$5.02M
RatioAll Sells
% Change vs. Prior
Ratio -100.0%Value -51.7%
By Industry
Software - Application
Buys9
Sells125
Buy $$1.27M
Sell $$181.31M
Ratio1:142.55
% Change vs. Prior
Ratio -98.4%Value -53.3%
Semiconductors
Buys0
Sells110
Buy $$0.00
Sell $$148.66M
RatioAll Sells
% Change vs. Prior
Ratio -100.0%Value -9.8%
Oil & Gas Midstream
Buys0
Sells11
Buy $$0.00
Sell $$131.13M
RatioAll Sells
Computer Hardware
Buys0
Sells96
Buy $$0.00
Sell $$126.24M
RatioAll Sells
Engineering & Construction
Buys2
Sells9
Buy $$83.33K
Sell $$124.84M
Ratio1:1498.13
Oil & Gas Refining & Marketing
Buys1
Sells9
Buy $$30.31K
Sell $$82.75M
Ratio1:2730.25
% Change vs. Prior
Ratio +inf%Value -1.9%
Software - Infrastructure
Buys3
Sells70
Buy $$188.93K
Sell $$68.52M
Ratio1:362.66
% Change vs. Prior
Ratio -61.5%Value -76.9%
Biotechnology
Buys8
Sells140
Buy $$3.75M
Sell $$55.53M
Ratio1:14.81
% Change vs. Prior
Ratio -26.9%Value -73.3%
Hardware, Equipment & Parts
Buys0
Sells64
Buy $$0.00
Sell $$49.29M
RatioAll Sells
% Change vs. Prior
Ratio -100.0%Value -95.0%
Drug Manufacturers - Specialty & Generic
Buys0
Sells24
Buy $$0.00
Sell $$27.95M
RatioAll Sells
Asset Management
Buys53
Sells6
Buy $$1.11M
Sell $$23.80M
Ratio1:21.50
Restaurants
Buys0
Sells15
Buy $$0.00
Sell $$23.67M
RatioAll Sells
Oil & Gas Exploration & Production
Buys4
Sells15
Buy $$2.12K
Sell $$22.18M
Ratio1:10469.58
% Change vs. Prior
Ratio -96.8%Value -99.1%
Medical - Diagnostics & Research
Buys5
Sells19
Buy $$2.28M
Sell $$18.21M
Ratio1:7.97
Medical - Healthcare Information Services
Buys6
Sells10
Buy $$18.34M
Sell $$286.16K
Ratio64.10:1
Transactions (1575)
Dell Technologies Inc. (DELL)
SLTA IV (GP), L.L.C. — Director
Shares
313
Price
$155.00
Total Value
$48.52K
Shares Held After
0
% of Holdings
100.0%
Dell Technologies Inc. (DELL)
SLTA IV (GP), L.L.C. — Director
Shares
8,408
Price
$155.00
Total Value
$1.30M
Shares Held After
18,726
% of Holdings
31.0%
Dell Technologies Inc. (DELL)
SLTA IV (GP), L.L.C. — Director
Shares
16,390
Price
$155.00
Total Value
$2.54M
Shares Held After
29,428
% of Holdings
35.8%
Dell Technologies Inc. (DELL)
SLTA IV (GP), L.L.C. — Director
Shares
14,149
Price
$155.00
Total Value
$2.19M
Shares Held After
39,618
% of Holdings
26.3%
Dell Technologies Inc. (DELL)
SLTA IV (GP), L.L.C. — Director
Shares
615
Price
$154.46
Total Value
$94.99K
Shares Held After
141
% of Holdings
81.3%
Dell Technologies Inc. (DELL)
SLTA IV (GP), L.L.C. — Director
Shares
1,362
Price
$154.46
Total Value
$210.37K
Shares Held After
313
% of Holdings
81.3%
Dell Technologies Inc. (DELL)
SLTA IV (GP), L.L.C. — Director
Shares
36,592
Price
$154.46
Total Value
$5.65M
Shares Held After
27,134
% of Holdings
57.4%
Dell Technologies Inc. (DELL)
SLTA IV (GP), L.L.C. — Director
Shares
71,331
Price
$154.46
Total Value
$11.02M
Shares Held After
45,818
% of Holdings
60.9%
Dell Technologies Inc. (DELL)
SLTA IV (GP), L.L.C. — Director
Shares
61,578
Price
$154.46
Total Value
$9.51M
Shares Held After
53,767
% of Holdings
53.4%
Dell Technologies Inc. (DELL)
SLTA IV (GP), L.L.C. — Director
Shares
95
Price
$153.14
Total Value
$14.55K
Shares Held After
756
% of Holdings
11.2%
Dell Technologies Inc. (DELL)
SLTA IV (GP), L.L.C. — Director
Shares
211
Price
$153.14
Total Value
$32.31K
Shares Held After
1,675
% of Holdings
11.2%
Dell Technologies Inc. (DELL)
SLTA IV (GP), L.L.C. — Director
Shares
5,666
Price
$153.14
Total Value
$867.69K
Shares Held After
63,726
% of Holdings
8.2%
Dell Technologies Inc. (DELL)
SLTA IV (GP), L.L.C. — Director
Shares
11,045
Price
$153.14
Total Value
$1.69M
Shares Held After
117,150
% of Holdings
8.6%
Dell Technologies Inc. (DELL)
SLTA IV (GP), L.L.C. — Director
Shares
9,535
Price
$153.14
Total Value
$1.46M
Shares Held After
115,345
% of Holdings
7.6%
CytomX Therapeutics, Inc. (CTMX)
BELVIN MARCIA — SVP, Chief Scientific Officer
Shares
31,492
Price
$6.42
Total Value
$202.27K
Shares Held After
300,760
% of Holdings
9.5%
ContextLogic Holdings Inc. (LOGC)
Bobbili Raja — Director
Shares
29,000
Price
$8.60
Total Value
$249.37K
Shares Held After
350,000
% of Holdings
8.3%
Dell Technologies Inc. (DELL)
SLTA V (GP), L.L.C. — Director
Shares
141
Price
$155.00
Total Value
$21.86K
Shares Held After
0
% of Holdings
100.0%
Dell Technologies Inc. (DELL)
SLTA V (GP), L.L.C. — Director
Shares
313
Price
$155.00
Total Value
$48.52K
Shares Held After
0
% of Holdings
100.0%
Dell Technologies Inc. (DELL)
SLTA V (GP), L.L.C. — Director
Shares
8,408
Price
$155.00
Total Value
$1.30M
Shares Held After
18,726
% of Holdings
31.0%
Dell Technologies Inc. (DELL)
SLTA V (GP), L.L.C. — Director
Shares
16,390
Price
$155.00
Total Value
$2.54M
Shares Held After
29,428
% of Holdings
35.8%
Dell Technologies Inc. (DELL)
SLTA V (GP), L.L.C. — Director
Shares
14,149
Price
$155.00
Total Value
$2.19M
Shares Held After
39,618
% of Holdings
26.3%
Dell Technologies Inc. (DELL)
SLTA V (GP), L.L.C. — Director
Shares
615
Price
$154.46
Total Value
$94.99K
Shares Held After
141
% of Holdings
81.3%
Dell Technologies Inc. (DELL)
SLTA V (GP), L.L.C. — Director
Shares
1,362
Price
$154.46
Total Value
$210.37K
Shares Held After
313
% of Holdings
81.3%
Dell Technologies Inc. (DELL)
SLTA V (GP), L.L.C. — Director
Shares
36,592
Price
$154.46
Total Value
$5.65M
Shares Held After
27,134
% of Holdings
57.4%
Dell Technologies Inc. (DELL)
SLTA V (GP), L.L.C. — Director
Shares
71,331
Price
$154.46
Total Value
$11.02M
Shares Held After
45,818
% of Holdings
60.9%
Dell Technologies Inc. (DELL)
SLTA V (GP), L.L.C. — Director
Shares
61,578
Price
$154.46
Total Value
$9.51M
Shares Held After
53,767
% of Holdings
53.4%
Dell Technologies Inc. (DELL)
SLTA V (GP), L.L.C. — Director
Shares
95
Price
$153.14
Total Value
$14.55K
Shares Held After
756
% of Holdings
11.2%
Dell Technologies Inc. (DELL)
SLTA V (GP), L.L.C. — Director
Shares
211
Price
$153.14
Total Value
$32.31K
Shares Held After
1,675
% of Holdings
11.2%
Dell Technologies Inc. (DELL)
SLTA V (GP), L.L.C. — Director
Shares
5,666
Price
$153.14
Total Value
$867.69K
Shares Held After
63,726
% of Holdings
8.2%
Dell Technologies Inc. (DELL)
SLTA V (GP), L.L.C. — Director
Shares
11,045
Price
$153.14
Total Value
$1.69M
Shares Held After
117,150
% of Holdings
8.6%
Dell Technologies Inc. (DELL)
SLTA V (GP), L.L.C. — Director
Shares
9,535
Price
$153.14
Total Value
$1.46M
Shares Held After
115,345
% of Holdings
7.6%
SentinelOne, Inc. (S)
Weingarten Tomer — Director
Shares
38,864
Price
$14.47
Total Value
$562.35K
Shares Held After
1,007,277
% of Holdings
3.7%
Roivant Sciences Ltd. (ROIV)
Venker Eric — President & Immunovant CEO
Shares
200,000
Price
$28.24
Total Value
$5.65M
Shares Held After
1,647,546
% of Holdings
10.8%
CRA INTERNATIONAL, INC. (CRAI)
Maleh Paul A — Director
Shares
75
Price
$159.15
Total Value
$11.94K
Shares Held After
115,113
% of Holdings
0.1%
CRA INTERNATIONAL, INC. (CRAI)
Maleh Paul A — Director
Shares
1,375
Price
$158.36
Total Value
$217.75K
Shares Held After
115,188
% of Holdings
1.2%
CRA INTERNATIONAL, INC. (CRAI)
Maleh Paul A — Director
Shares
275
Price
$157.66
Total Value
$43.36K
Shares Held After
116,563
% of Holdings
0.2%
CRA INTERNATIONAL, INC. (CRAI)
Maleh Paul A — Director
Shares
1,575
Price
$156.33
Total Value
$246.21K
Shares Held After
116,838
% of Holdings
1.3%
CRA INTERNATIONAL, INC. (CRAI)
Maleh Paul A — Director
Shares
1,704
Price
$155.00
Total Value
$264.12K
Shares Held After
118,413
% of Holdings
1.4%
CRA INTERNATIONAL, INC. (CRAI)
Maleh Paul A — Director
Shares
1,484
Price
$153.91
Total Value
$228.40K
Shares Held After
120,117
% of Holdings
1.2%
CRA INTERNATIONAL, INC. (CRAI)
Maleh Paul A — Director
Shares
1,012
Price
$152.66
Total Value
$154.49K
Shares Held After
121,601
% of Holdings
0.8%
Accel Entertainment, Inc. (ACEL)
Rubenstein Andrew H. — Director
Shares
3,938
Price
$11.23
Total Value
$44.22K
Shares Held After
3,956,368
% of Holdings
0.1%
Enliven Therapeutics, Inc. (ELVN)
Collins Helen Louise — CHIEF MEDICAL OFFICER
Shares
5,000
Price
$27.76
Total Value
$138.80K
Shares Held After
25,000
% of Holdings
16.7%
Pacira BioSciences, Inc. (PCRX)
Froimson Mark — Director
Shares
500
Price
$21.81
Total Value
$10.90K
Shares Held After
20,136
% of Holdings
2.4%
Stoke Therapeutics, Inc. (STOK)
Allan Jonathan — GENERAL COUNSEL & CORP SEC
Shares
1,791
Price
$33.38
Total Value
$59.78K
Shares Held After
33,464
% of Holdings
5.1%
Pacira BioSciences, Inc. (PCRX)
SLONIN JONATHAN — Chief Medical Officer
Shares
3,261
Price
$22.82
Total Value
$74.42K
Shares Held After
223,640
% of Holdings
1.4%
Stoke Therapeutics, Inc. (STOK)
Allan Jonathan — GENERAL COUNSEL & CORP SEC
Shares
2,476
Price
$32.74
Total Value
$81.06K
Shares Held After
35,255
% of Holdings
6.6%
Stoke Therapeutics, Inc. (STOK)
Hoitt Jason — Chief Patient Officer
Shares
748
Price
$33.38
Total Value
$24.96K
Shares Held After
12,207
% of Holdings
5.8%
Stoke Therapeutics, Inc. (STOK)
Hoitt Jason — Chief Patient Officer
Shares
1,033
Price
$32.74
Total Value
$33.82K
Shares Held After
12,955
% of Holdings
7.4%
Stoke Therapeutics, Inc. (STOK)
Leggett Thomas — Chief Financial Officer
Shares
922
Price
$33.38
Total Value
$30.77K
Shares Held After
12,554
% of Holdings
6.8%
Stoke Therapeutics, Inc. (STOK)
Leggett Thomas — Chief Financial Officer
Shares
1,274
Price
$32.74
Total Value
$41.71K
Shares Held After
13,476
% of Holdings
8.6%
Showing 851–900 of 1575 transactions (page 18 of 32)